{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:55:26Z","timestamp":1790211326436,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14230-9","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:20:03Z","timestamp":1746127203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognosis, immunological features and potential mechanisms of HKR1 in prostate cancer via single-cell and bulk RNA-sequencing"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"issue":"1","key":"14230_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"Cancer J Clin"},{"key":"14230_CR2","doi-asserted-by":"crossref","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate Cancer. Cold Spring Harbor Perspect Med 2018, 8(12).","DOI":"10.1101\/cshperspect.a030361"},{"issue":"6","key":"14230_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","volume":"61","author":"MM Center","year":"2012","unstructured":"Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079\u201392.","journal-title":"Eur Urol"},{"issue":"S1","key":"14230_CR4","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","volume":"31","author":"AJ Evans","year":"2018","unstructured":"Evans AJ. Treatment effects in prostate cancer. Mod Pathology: Official J United States Can Acad Pathol Inc. 2018;31(S1):S110\u2013121.","journal-title":"Mod Pathology: Official J United States Can Acad Pathol Inc"},{"issue":"3","key":"14230_CR5","doi-asserted-by":"publisher","first-page":"Fso643","DOI":"10.2144\/fsoa-2020-0154","volume":"7","author":"G Tarantino","year":"2021","unstructured":"Tarantino G, Crocetto F, Vito CD, Martino R, Pandolfo SD, Creta M, Aveta A, Buonerba C, Imbimbo C. Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study. Future Sci OA. 2021;7(3):Fso643.","journal-title":"Future Sci OA"},{"issue":"1","key":"14230_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352.","journal-title":"Eur Urol"},{"issue":"22","key":"14230_CR7","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1158\/1078-0432.CCR-17-0019","volume":"23","author":"M Bilusic","year":"2017","unstructured":"Bilusic M, Madan RA, Gulley JL. Immunotherapy of prostate cancer: facts and hopes. Clin cancer Research: Official J Am Association Cancer Res. 2017;23(22):6764\u201370.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"10","key":"14230_CR8","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.xcrm.2023.101199","volume":"4","author":"D Sridaran","year":"2023","unstructured":"Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP. Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach. Cell Rep Med. 2023;4(10):101199.","journal-title":"Cell Rep Med"},{"issue":"4","key":"14230_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1158\/1078-0432.CCR-21-1483","volume":"28","author":"TB Dorff","year":"2022","unstructured":"Dorff TB, Narayan V, Forman SJ, Zang PD, Fraietta JA, June CH, Haas NB, Priceman SJ. Novel redirected T-Cell immunotherapies for advanced prostate Cancer. Clin cancer Research: Official J Am Association Cancer Res. 2022;28(4):576\u201384.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"key":"14230_CR10","doi-asserted-by":"publisher","first-page":"217155","DOI":"10.1016\/j.canlet.2024.217155","volume":"601","author":"D Liu","year":"2024","unstructured":"Liu D, Wang L, Guo Y. Advances in and prospects of immunotherapy for prostate cancer. Cancer Lett. 2024;601:217155.","journal-title":"Cancer Lett"},{"issue":"15","key":"14230_CR11","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1242\/dev.132605","volume":"144","author":"G Ecco","year":"2017","unstructured":"Ecco G, Imbeault M, Trono D. KRAB zinc finger proteins. Development. 2017;144(15):2719\u201329.","journal-title":"Development"},{"issue":"4","key":"14230_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/13892029113149990002","volume":"14","author":"A Lupo","year":"2013","unstructured":"Lupo A, Cesaro E, Montano G, Zurlo D, Izzo P, Costanzo P. KRAB-Zinc finger proteins: A repressor family displaying multiple biological functions. Curr Genom. 2013;14(4):268\u201378.","journal-title":"Curr Genom"},{"issue":"8","key":"14230_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1101\/gr.8.8.791","volume":"8","author":"EE Eichler","year":"1998","unstructured":"Eichler EE, Hoffman SM, Adamson AA, Gordon LA, McCready P, Lamerdin JE, Mohrenweiser HW. Complex beta-satellite repeat structures and the expansion of the zinc finger gene cluster in 19p12. Genome Res. 1998;8(8):791\u2013808.","journal-title":"Genome Res"},{"key":"14230_CR14","doi-asserted-by":"crossref","unstructured":"Ayyanathan K, Lechner MS, Bell P, Maul GG, Schultz DC, Yamada Y, Tanaka K, Torigoe K, Rauscher FJ 3. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev. 2003;17(15):1855\u201369.","DOI":"10.1101\/gad.1102803"},{"key":"14230_CR15","doi-asserted-by":"publisher","first-page":"109996","DOI":"10.1016\/j.envres.2020.109996","volume":"190","author":"X Song","year":"2020","unstructured":"Song X, Zhou X, Yang F, Liang H, Wang Z, Li R, Miao M, Yuan W. Association between prenatal bisphenol a exposure and promoter hypermethylation of CAPS2, TNFRSF25, and HKR1 genes in cord blood. Environ Res. 2020;190:109996.","journal-title":"Environ Res"},{"issue":"1","key":"14230_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12920-018-0334-1","volume":"11","author":"Q Zeng","year":"2018","unstructured":"Zeng Q, Chen X, Ning C, Zhu Q, Yao Y, Zhao Y, Luan F. Methylation of the genes ROD1, NLRC5, and HKR1 is associated with aging in Hainan centenarians. BMC Med Genom. 2018;11(1):7.","journal-title":"BMC Med Genom"},{"issue":"1","key":"14230_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-019-0672-7","volume":"11","author":"M Altuna","year":"2019","unstructured":"Altuna M, Urd\u00e1noz-Casado A, S\u00e1nchez-Ruiz de Gordoa J, Zelaya MV, Labarga A, Lepesant JMJ, Rold\u00e1n M, Blanco-Luquin I, Perdones \u00c1, Larumbe R, et al. DNA methylation signature of human hippocampus in Alzheimer\u2019s disease is linked to neurogenesis. Clin Epigenetics. 2019;11(1):91.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"14230_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-1119(98)00464-8","volume":"222","author":"T Oguri","year":"1998","unstructured":"Oguri T, Katoh O, Takahashi T, Isobe T, Kuramoto K, Hirata S, Yamakido M, Watanabe H. The Kr\u00fcppel-type zinc finger family gene, HKR1, is induced in lung cancer by exposure to platinum drugs. Gene. 1998;222(1):61\u20137.","journal-title":"Gene"},{"issue":"3","key":"14230_CR19","doi-asserted-by":"publisher","first-page":"e120129","DOI":"10.1016\/j.urolonc.2015.10.009","volume":"34","author":"SM Hunter","year":"2016","unstructured":"Hunter SM, Rowley SM, Clouston D, Li J, Lupat R, Krishnananthan N, Risbridger G, Taylor R, Bolton D, Campbell IG, et al. Searching for candidate genes in Familial BRCAX mutation carriers with prostate cancer. Urol Oncol. 2016;34(3):e120129\u2013116.","journal-title":"Urol Oncol"},{"issue":"1","key":"14230_CR20","doi-asserted-by":"publisher","first-page":"e1964189","DOI":"10.1080\/2162402X.2021.1964189","volume":"10","author":"J Sun","year":"2021","unstructured":"Sun J, Shi R, Zhang X, Fang D, Rauch J, Lu S, Wang X, K\u00e4smann L, Ma J, Belka C, et al. Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy. Oncoimmunology. 2021;10(1):e1964189.","journal-title":"Oncoimmunology"},{"issue":"10","key":"14230_CR21","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.7150\/thno.56202","volume":"11","author":"R Shi","year":"2021","unstructured":"Shi R, Bao X, Unger K, Sun J, Lu S, Manapov F, Wang X, Belka C, Li M. Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients. Theranostics. 2021;11(10):5061\u201376.","journal-title":"Theranostics"},{"issue":"21","key":"14230_CR22","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"1","key":"14230_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, Bian X, Zhu Y, Yu Y, Liu F, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23(1):87\u201398.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"14230_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X, Dong Z. Targeting AURKA in cancer: molecular mechanisms and opportunities for Cancer therapy. Mol Cancer. 2021;20(1):15.","journal-title":"Mol Cancer"},{"key":"14230_CR25","doi-asserted-by":"publisher","first-page":"153303382211106","DOI":"10.1177\/15330338221110673","volume":"21","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chen J, Lin X, Zheng J, Li S, Zheng X. A prognostic nomogram for predicting overall survival in patients with Small-Cell carcinoma of the uterine cervix: A SEER Population-Based study. Technol Cancer Res Treat. 2022;21:15330338221110673.","journal-title":"Technol Cancer Res Treat"},{"key":"14230_CR26","doi-asserted-by":"crossref","unstructured":"Wattanawongdon W, Bartpho TS, Tongtawee T. Expression of Matrix Metalloproteinase-7 Predicts Poor Prognosis in Gastric Cancer. BioMed research international 2022, 2022:2300979.","DOI":"10.1155\/2022\/2300979"},{"issue":"4","key":"14230_CR27","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s11033-021-07064-8","volume":"49","author":"M Yan","year":"2022","unstructured":"Yan M, Yin X, Zhang L, Cui Y, Ma X. High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma. Mol Biol Rep. 2022;49(4):2607\u201318.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"14230_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/1878-0261.12407","volume":"13","author":"M Machnik","year":"2019","unstructured":"Machnik M, Cylwa R, Kie\u0142czewski K, Biecek P, Liloglou T, Mackiewicz A, Oleksiewicz U. The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data. Mol Oncol. 2019;13(4):701\u201324.","journal-title":"Mol Oncol"},{"key":"14230_CR29","doi-asserted-by":"crossref","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive integration of Single-Cell data. Cell. 2019;177(7):1888\u2013e19021821.","DOI":"10.1016\/j.cell.2019.05.031"},{"issue":"1","key":"14230_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger I, Fotakis G, Offermann A, Goveia J, Daum S, Salcher S, Noureen A, Timmer-Bosscha H, Sch\u00e4fer G, Walenkamp A, et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer. 2022;21(1):132.","journal-title":"Mol Cancer"},{"key":"14230_CR31","doi-asserted-by":"crossref","unstructured":"Song H, Weinstein HNW, Allegakoen P, Wadsworth MH 2nd, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell States. Nat Commun. 2022;13(1):141.","DOI":"10.1038\/s41467-021-27322-4"},{"issue":"43","key":"14230_CR32","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"14230_CR33","doi-asserted-by":"publisher","first-page":"zcaa046","DOI":"10.1093\/narcan\/zcaa046","volume":"3","author":"BM Greulich","year":"2021","unstructured":"Greulich BM, Plotnik JP, Jerde TJ, Hollenhorst PC. Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target. NAR cancer. 2021;3(1):zcaa046.","journal-title":"NAR cancer"},{"issue":"4","key":"14230_CR34","first-page":"2224","volume":"13","author":"H Deng","year":"2021","unstructured":"Deng H, Zhu B, Dong Z, Jiang H, Zhao X, Wu S. miR-214-5p targeted by LncRNA DANCR mediates TGF-\u03b2 signaling pathway to accelerate proliferation, migration and inhibit apoptosis of prostate cancer cells. Am J Translational Res. 2021;13(4):2224\u201340.","journal-title":"Am J Translational Res"},{"issue":"1","key":"14230_CR35","first-page":"378","volume":"16","author":"J Wan","year":"2018","unstructured":"Wan J, Zhang J, Zhang J. Expression of p53 and its mechanism in prostate cancer. Oncol Lett. 2018;16(1):378\u201382.","journal-title":"Oncol Lett"},{"issue":"Pt 3","key":"14230_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.semcancer.2022.02.017","volume":"86","author":"M Mughees","year":"2022","unstructured":"Mughees M, Kaushal JB, Sharma G, Wajid S, Batra SK, Siddiqui JA. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis. Sem Cancer Biol. 2022;86(Pt 3):497\u2013512.","journal-title":"Sem Cancer Biol"},{"key":"14230_CR37","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"key":"14230_CR38","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","volume":"11","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, Meylan M, de Reyni\u00e8s A, Saut\u00e8s-Fridman C, Fridman WH. The tumor microenvironment in the response to immune checkpoint Blockade therapies. Front Immunol. 2020;11:784.","journal-title":"Front Immunol"},{"issue":"8","key":"14230_CR39","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-19-2948","volume":"80","author":"HR Cha","year":"2020","unstructured":"Cha HR, Lee JH, Ponnazhagan S. Revisiting immunotherapy: A focus on prostate Cancer. Cancer Res. 2020;80(8):1615\u201323.","journal-title":"Cancer Res"},{"key":"14230_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1471-2164-10-277","volume":"10","author":"UT Shankavaram","year":"2009","unstructured":"Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, Reinhold WC, Pommier Y, Weinstein JN. CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics. 2009;10:277.","journal-title":"BMC Genomics"},{"issue":"17","key":"14230_CR41","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1158\/1078-0432.CCR-15-0335","volume":"21","author":"WC Reinhold","year":"2015","unstructured":"Reinhold WC, Sunshine M, Varma S, Doroshow JH, Pommier Y. Using cellminer 1.6 for systems Pharmacology and genomic analysis of the NCI-60. Clin cancer Research: Official J Am Association Cancer Res. 2015;21(17):3841\u201352.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"1\u20132","key":"14230_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-020-03845-0","volume":"474","author":"B Yang","year":"2020","unstructured":"Yang B, Zhang D, Qian J, Cheng Y. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP\/TIMP\/NF-\u03baB system. Mol Cell Biochem. 2020;474(1\u20132):199\u2013208.","journal-title":"Mol Cell Biochem"},{"key":"14230_CR43","doi-asserted-by":"crossref","unstructured":"Elhasasna H, Khan R, Bhanumathy KK, Vizeacoumar FS, Walke P, Bautista M, Dahiya DK, Maranda V, Patel H, Balagopal A et al. A drug repurposing screen identifies fludarabine phosphate as a potential therapeutic agent for N-MYC overexpressing neuroendocrine prostate cancers. Cells 2022, 11(14).","DOI":"10.3390\/cells11142246"},{"issue":"3","key":"14230_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1039\/C4MB00384E","volume":"11","author":"P Dowling","year":"2015","unstructured":"Dowling P, Pollard D, Larkin A, Henry M, Meleady P, Gately K, O\u2019Byrne K, Barr MP, Lynch V, Ballot J, et al. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Mol Biosyst. 2015;11(3):743\u201352.","journal-title":"Mol Biosyst"},{"key":"14230_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2020.01.029","volume":"475","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wei Q, Tang Y, Yuanyuan W, Luo Q, Zhao H, He M, Wang H, Zeng Q, Lu W, et al. Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer. Cancer Lett. 2020;475:43\u201352.","journal-title":"Cancer Lett"},{"key":"14230_CR46","doi-asserted-by":"crossref","unstructured":"Jiang M, Lu Y, Duan D, Wang H, Man G, Kang C, Abulimiti K, Li Y. Systematic Investigation of mRNA N (6)-Methyladenosine Machinery in Primary Prostate Cancer. Disease markers 2020, 2020:8833438.","DOI":"10.1155\/2020\/8833438"},{"issue":"1","key":"14230_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12935-020-01705-x","volume":"21","author":"P Shen","year":"2021","unstructured":"Shen P, Qu L, Wang J, Ding Q, Zhou C, Xie R, Wang H, Ji G. LncRNA LINC00342 contributes to the growth and metastasis of colorectal cancer via targeting miR-19a-3p\/NPEPL1 axis. Cancer Cell Int. 2021;21(1):105.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"14230_CR48","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1186\/s12885-021-08829-x","volume":"21","author":"R Liu","year":"2021","unstructured":"Liu R, Yang X. LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p\/CNPY2 axis. BMC Cancer. 2021;21(1):1163.","journal-title":"BMC Cancer"},{"key":"14230_CR49","doi-asserted-by":"publisher","first-page":"1017635","DOI":"10.3389\/fonc.2022.1017635","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Zhou R, Sun B, Jin X, Chen Y, Xu X. Prognostic significance of LncRNA AP004608.1 in prostate cancer. Front Oncol. 2022;12:1017635.","journal-title":"Front Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14230-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14230-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14230-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:02:43Z","timestamp":1746129763000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14230-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14230"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14230-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current research was approved by the Institutional Review Board of Shanghai General Hospital and all patients signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"822"}}